Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

High False-Positive Rate Found in Consumer Genetic Tests

Follow-up reviews of results from direct-to-consumer genetic tests show 40 percent of the actionable gene variations reported in the tests, including some indicating disease risk, were erroneous. . . . → Read More: High False-Positive Rate Found in Consumer Genetic Tests

Trials Show Pain Drug Reduces Post-Surgery Opioid Use

Initial results from two late-stage clinical trials show an experimental pain drug with non-opioid ingredients reduces the use of opioid pain relievers following surgery, compared to a placebo and standard care. . . . → Read More: Trials Show Pain Drug Reduces Post-Surgery Opioid Use

Quick Bacterial Blood Detection Gains Breakthrough Tag

A technology that detects dangerous bacteria in patients’ blood samples in less than an hour received a breakthrough medical device designation from the U.S. Food and Drug Administration. . . . → Read More: Quick Bacterial Blood Detection Gains Breakthrough Tag

Trial Shows Patch Feasible for Heart Rhythm Detection

Results from a clinical trial show a wearable patch, applied and used by older adults in their homes, detects more heart rhythm problems than waiting to see a doctor, the usual way these problems are detected. . . . → Read More: Trial Shows Patch Feasible for Heart Rhythm Detection

FDA Clears Consumer Genetic Breast Cancer Risk Tests

The Food and Drug Administration authorized the first direct-to-consumer tests of genetic risk for cancer, in this case 3 variations of genes associated with higher risk of breast and ovarian cancer. . . . → Read More: FDA Clears Consumer Genetic Breast Cancer Risk Tests

Trial Shows Reduction in Huntington Disease Protein

First results from a clinical trial show an experimental therapy reduces production of a protein damaging nerve cells in people with Huntington disease. . . . → Read More: Trial Shows Reduction in Huntington Disease Protein

Precision Cancer Drug Shown Effective in Adults, Children

Results from 3 clinical trials show most cancer patients given an experimental drug that directly addresses a specific genetic mutation respond to the treatments, despite their cancers occurring in a variety of organs. . . . → Read More: Precision Cancer Drug Shown Effective in Adults, Children

Trial Shows Treatment Desensitizes Peanut Allergies

A large-scale clinical trial shows a preventive treatment desensitizes peanut allergies in children, with most participants able to tolerate substantial amounts of peanut proteins after 1 year. . . . → Read More: Trial Shows Treatment Desensitizes Peanut Allergies

NIH Exec: Research Offers Opioid Crisis Solutions

The director of the National Institute on Drug Abuse says recent research in neuroscience and pharmacology reveals possible pathways out of the current epidemic of opioid addiction and overdose deaths. . . . → Read More: NIH Exec: Research Offers Opioid Crisis Solutions

FDA Clears First Blood Test for Concussions

The Food and Drug Administration authorized for marketing in the U.S. a blood test that screens for chemical indicators in the blood for concussions, a form of traumatic brain injury. . . . → Read More: FDA Clears First Blood Test for Concussions